Your Employer Owes You More: Read the Fine Print

By Harvey Specter Jr. | Law, Business & Power | PUCKA by News Beast

---

Three stories dropped this week that have nothing to do with each other on the surface. A law firm associate who survived a heart attack and then watched his partnership track disappear. A tech giant settling child safety claims for $17 billion. A prediction market platform facing state enforcement action for doing what it believed federal law permitted. Three different industries, three different defendants — and the exact same underlying dynamic: the written agreement said one thing, and the people with power did another.

That dynamic is the only law lesson worth teaching today.

Start with the Troutman Pepper Locke case, because it's the most personal and the most instructive. An associate — by all accounts a high performer on a partnership trajectory — suffers what is clinically described as a widow-maker heart attack. At the office. He survives. Then, according to the lawsuit he has now filed, the firm begins moving the goalposts. The billing targets shift. The partnership timeline lengthens. The expectations that were never written down suddenly become the expectations that matter most. And the $3,000 charged to his account for "cabinets" — I'll let you read the full complaint for that detail — becomes a symbol of something larger: an institution treating a human being as a liability to be managed off the books.

This happens everywhere. Not always with heart attacks. Usually with nothing so dramatic. A performance improvement plan that appears six weeks after you ask about promotion. A restructuring that eliminates exactly one role. A reference that is technically accurate and professionally lethal. The law calls some of this constructive dismissal, some of it disability discrimination, some of it breach of implied contract. But before you file anything, before you engage a single solicitor, you need to understand what you actually have in writing and what you were relying on that was never committed to paper.

In Malta, the Employment and Industrial Relations Act, Chapter 452 of the Laws of Malta, gives employees more protection than most people realise and less than they assume. The implied terms of your contract — the things your employer always did, the way they always treated advancement, the oral promises made in performance reviews — can constitute enforceable contractual terms if they were consistent, relied upon, and not contradicted by the written agreement. The Troutman case will turn on this. So will the next case filed by the next associate at the next firm who discovers that institutional loyalty is a one-way street.

The Oura sleep-tracking lawsuit raises a different version of the same problem. Oura markets a ring that tracks your sleep stages — REM, deep, light — with a precision that implies medical-grade accuracy. The lawsuit argues that precision is overstated. That the AI model generating the sleep data is producing outputs that feel exact but are not. That consumers are making health decisions based on numbers that look authoritative and aren't. The legal theory here is consumer protection: misrepresentation, false advertising, breach of implied warranty of fitness. But the real story is about trust and the gap between what a product implies and what it delivers.

This gap is the unwritten side of every contract. And it is always the side that matters.

In EU law, the Unfair Commercial Practices Directive — Directive 2005/29/EC — prohibits misleading representations about the characteristics of a product, including its accuracy and the results that can be expected from its use. In Malta, this is transposed through the Consumer Affairs Act and enforced by the Malta Competition and Consumer Affairs Authority. If a product's marketing implies clinical precision, and the underlying technology cannot deliver that precision, the manufacturer has a problem that no terms and conditions page can fully immunise against. The key word is "implies." You don't have to say "this is medically certified." You just have to let the consumer reasonably believe it. Reasonable belief is the standard. The Oura case will test exactly where that line sits for AI-generated health data — and the answer will matter for every wearable, every app, every wellness platform that monetises the appearance of precision.

Then there is Kalshi. Connecticut has moved from defending its position to pursuing an injunction, financial penalties, and disgorgement of revenue generated in the state. That last part — the return of revenue — is the most significant and the least discussed. Connecticut is not just saying stop. It is saying give back everything you made while doing this. That is the enforcement posture of a regulator that believes it has a clean case and wants to make an example.